Literature DB >> 7275357

Solubilization and partial characterization of a tumor-rejection antigen from an ultraviolet light-induced murine tumor.

J H Ransom, C L Schengrund, G L Bartlett.   

Abstract

Tumor rejection antigen (TRA) of an ultraviolet-light-induced murine skin tumor was solubilized, fractionated and partially characterized. Subcellular fractions were prepared by differential centrifugation of tumor cells that had been ruptured via nitrogen cavitation. Only the 110,000-g membrane fraction induced significant tumor protection, as determined by in vivo immunization and challenge assays. Extraction of the membrane fraction with 3 M KCI resulted in solubilization of material that could induce in vivo tumor-rejection immunity. Both the membrane fraction and soluble extract had a limited effective dose range. The KCI extract was separated on a Sepharose, CL-6B column in the presence of 6 M guanidine-HCI. Only one of five fraction pools (molecular weight range of 76,000-127,000 daltons) was immunogenic. It contained at least eight protein bands by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), but no lipid components. This immunogenic Sepharose fraction was chromatographed on a Sephadex G-150 column. Each of the four Sephadex fraction pools was immunogenic. One protein component was common to each of those fractions. It migrated as a single 76,000-dalton band on SDS-PAGE and contained [14C]-leucine and [3H]-glucosamine that had been incorporated during cell growth. These results suggest that the TRA of this tumor is a 76,000-dalton glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275357     DOI: 10.1002/ijc.2910270419

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  The effect of purification on the immunogenicity of tumor-specific transplantation antigens.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  Purification of immunoprotective tumor antigens by preparative isotachophoresis.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Assignment of the gene encoding for Meth A tumour rejection antigen (TATA) to chromosome 12 of the mouse.

Authors:  L W Law
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

4.  Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes.

Authors:  Charles A Gullo; William Yk Hwang; Chye K Poh; Melvin Au; Geraline Cow; Gerrard Teoh
Journal:  J Immune Based Ther Vaccines       Date:  2008-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.